Literature DB >> 22735506

The use of microdebrider for the treatment of accessory axillary breast.

Sun Mingfa Jeremy1, Chong Si Jack, Yeow Kok Leng Vincent, Woo Kok Yen Evan.   

Abstract

Accessory axillary breast tissue can be fairly common occurring in 2-6% of women. Treatment modalities thus far include direct excision as well as liposuction. While direct excision allows for accessible and adequate tissue resection, it results in long unsightly scars and the creation of significant amount of dead space. This may be complicated by seroma and haematoma formation. Liposuction is not without its drawbacks either. It is often very difficult to remove fibro-glandular breast tissue resulting in inadequate excision, thus leaving behind a visible core of breast tissue. This has led some surgeons to use a combination of direct excision and liposuction to manage accessory axillary breast tissue. Hence, we present the use of the microdebrider for sharp and precise excision of accessory axillary breast tissue. This day procedure can be performed through a single 5-mm incision which is well hidden in the axillary skin folds while allowing the operator the amount of control needed to accurately remove fibro-glandular breast tissue and restore an aesthetically pleasing contour to the axilla.
Copyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22735506     DOI: 10.1016/j.bjps.2012.05.023

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  2 in total

1.  A Study of Evaluation and Management of Rare Congenital Breast Diseases.

Authors:  Rikki Singal; Sudhir Kumar Mehta; Jyoti Bala; Muzzafar Zaman; Amit Mittal; Guarav Gupta; Samer Rudra; Samita Singal
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Surgery for fibroadenoma arising from axillary accessory breast.

Authors:  Sung Ryul Lee
Journal:  BMC Womens Health       Date:  2021-04-07       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.